Genetic variation in paraoxonase-2 is associated with variation in plasma lipoproteins in Canadian Oji-Cree

Clinical Genetics

Volumn 54, Issue 5, 1998, Pages 394-399

  Hegele, Robert A ^a   Harris, Stewart B ^b   Connelly, Philip W ^c   Hanley, Anthony J G ^d   Tsui, Lap Chee ^e   Zinman, Bernard ^d   Scherer, Stephen W ^e  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Genetic variation; Paraoxonase 2; Plasma lipoprotein

Indexed keywords

ALANINE; APOLIPOPROTEIN B; ARYLESTERASE; GLYCINE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AMINO ACID SUBSTITUTION; ARTICLE; CANADA; CHROMOSOME 7Q; CODON; DIET RESTRICTION; ETHNIC GROUP; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL;

ALOCASIA MACRORRHIZOS;

EID: 0031740464     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1998.tb03752.x     Document Type: Article

References (33)

1. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994: 265: 2037-2048.
2. Schork NJ. Genetically complex cardiovascular traits: origins, problems, and potential solutions. Hypertension 1997: 29: 145-149.
3. Hegele RA. The genetic basis of atherosclerosis. Int J Clin Lab Res 1997: 27: 2-13.
4. Hegele RA. Candidate genes, small effects, and the prediction of atherosclerosis. Crit Rev Clin Lab Sci 1997: 34: 343-367.
5. Hegele RA, Brunt JH, Connelly PW. A polymorphism of the angiotensinogen gene is associated with variation in blood pressure in a genetic isolate. Circulation 1994: 90: 2207-2212.
6. Hegele RA, Evans AJ, Tu L, Ip G, Brunt JH, Connelly PW. A gene-gender interaction affecting lipoproteins in a genetic isolate. Arterioscler Thromb 1994: 14: 671-678.
7. Hegele RA, Brunt JH, Connelly PW. A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate. Arterioscler Thromb Vasc Biol 1995: 15: 89-95.
8. Hegele RA, Brunt JH, Connelly PW. Multiple genetic determinants of variation of plasma lipoproteins in Alberta Hutterites. Arterioscler Thromb Vasc Biol 1995: 15: 861-871.
9. Hegele RA, Brunt JH, Connelly PW. Genetic variation on chromosome 1 associated with variation in body fat distribution in men. Circulation 1995: 92: 1089-1093.
10. Hegele RA, Breckenridge WC, Brunt JH, Connelly PW. Genetic variation in factor VII associated with variation in plasma lipoprotein(a) concentration. Arterioscler Thromb Vasc Biol 1997: 17: 1701-1706.
11. Hegele RA, Brunt JH, Connelly PW. Genetic and biochemical factors associated with variation in blood pressure in a genetic isolate. Hypertension 1996: 27: 308-312.
12. La Du BN. Structural and functional diversity of paraoxonases. Nat Med 1996: 2: 1186-1187.
13. Primo-Parmo SL, Sorenson RC, Telber J, La Du BN. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 1996: 33: 498-507.
14. Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA. Paraxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 1996: 7: 69-76.
15. Ruiz J, Blanche H, James RW, Blatter-Garin MC, Vaisse C, Charpentier G, Cohen N, Morabia A, Passa P, Froguel P. Gln-Arg 192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 1995: 346: 869-872.
16. Serrato M, Marian AJ. A variant of human paraoxonase/ arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J Clin Invest 1995: 96: 3005-3008.
17. Odawara M, Tachi Y, Yamashita K. Paraoxonase polymorphism (Gln-Arg 192) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus. J Clin Endo Metab 1997: 82: 2257-2260.
18. Snaghera DK, Saha N, Aston CE, Kamboh MI. Genetic polymorphism of paraoxonase and the risk of coronary heart disease. Arterioscler Thromb Vasc Biol 1997: 17: 1067-1073.
19. Antikainen M, Murtomaki S, Syvaine M, Pahlman R, Tahvanainen E, Jaunianen M. The Gln-Arg 191 polymorphism of the paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. J Clin Invest 1996: 98: 883-885.
20. Herrmann SM, Blanc H, Poirier O, Arveller D, Luc G, Evans A, Marques-Vidal P, Bard JM, Cambien F. The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM study. Atherosclerosis 1996: 126: 299-303.
21. Hegele RA, Connelly PW, Hanley AJ, Sun F, Harris SB, Zinman B. Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians. Arterioscler Thromb Vasc Biol 1997: 17: 1060-1066.
22. Hegele RA, Connelly PW, Scherer SW, Hanley AJ, Harris SB, Tsui LC, Zinman B. Paraoxonase-2 G148 variant in an aboriginal Canadian girl with non-insulin-dependent diabetes. Lancet 1997: 350: 785.
23. Hegele RA, Connelly PW, Scherer SW, Hanley AJ, Harris SB, Tsui LC, Zinman B. Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997: 82: 3373-3377.
24. Sanghera DK, Aston CE, Saha N, Kamboh MI. DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease. Am J Hum Genet 1998: 62: 36-44.
25. Heinecke JW, Lusis AJ. Paraoxonase-gene polymorphisms associated with coronary heart disease: support for the oxidative damage hypothesis? Am J Hum Genet 1998: 62: 20-24.
26. Harris SB, Gittelsohn J, Hanley AJG, Barnie A, Wolever TMS, Gao J, Logan A, Zinman B. The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care 1997: 20: 185-197.
27. World Health Organization (WHO) Expert Committee on Diabetes Mellitus. Second report. Geneva; WHO Technical Report Series 646, 1980.
28. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979: 28: 1039-1057.
29. SAS Institute. SAS STAT Guide for personal computers (version 6.12). Cary, NC, 1995.
30. Blatter M-C, James RW, Messmer S, Barja F, Pometta D. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein K-45. Eur J Biochem 1993: 211: 871-879.
31. Saha N, Roy AC, Teo SH, Tay JSH, Ratnam SS. Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins. Clin Genet 1991: 40: 277-282.
32. Mackness MI, Harty D, Bhatnagar D, Winocour PH, Arrol S, Ishola M, Durrington PN. Serum paraoxonase activity in familial hypercholesterolemia and insulin-dependent diabetes mellitus. Atherosclerosis 1991: 86: 193-199.
33. Pavkovic E, Simeon V, Reiner E, Sucic M, Lipovac V. Serum paraoxonase and cholinesterase activities in individuals with lipid and glucose metabolism disorders. Chem Biol Interact 1993: 87: 179-182.